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Introduction
Leiomyosarcoma  is  a  rare  tumor  of  the  penile
mesechymal tissue. Because of the small number of
cases reported so far, the conclusions about treat-
ment  and  prognosis  are  equivocal.1 We  report  an
additional case,and attempt a review in the literature.
Case report
A 78-year-old farm worker presented with a 3-year
history of gradual painless swelling of the penis. His
medical  history  was  remarkable  for  generalized
vascular  disease and diabetes mellitus. During the
physical examination a non-mobile hard mass was
palpated involving the base and the midshaft of the
penis. The glans penis was normal and no regional
lymphadenopathy  was  found. Serum  biochemistry
and full blood count were normal. A CT showed a
soft mass lesion involving the corpora cavernosa of
the penis, but no evidence of metastatic disease.With
the  presumptive  diagnosis  of  penile  sarcoma  the
patient underwent a radical penectomy with perineal
urethrostomy. Macroscopically, a tumor measuring 
8 ´ 8 ´ 14 cm was found to arise from the corpora,
making the distinction between them almost impos-
sible. The  urethra and glans were free of  invasion
(Fig. 1). Microscopically, the tumor had the features
of high-grade sarcoma,being composed of neoplastic
spindle-shaped  cells, with  eosinophilic  cytoplasm
arranged  in  fascicles. The  cells  showed  moderate
nuclear atypia, with hyperchromatic nuclei and the
mitotic  rate  was  ￿ ve  per  high-power  ￿ eld. On
immunohistochemical staining, the tumor cells were
positive  for  vimentin  and  SMA  (smooth  muscle
antigen) (Fig. 2) and negative for desmin and S-100
protein. In  conclusion, the  tumor  proved  to  be  a
leiomyosarcoma. The  patient  made  an  uneventful
recovery and is  well, with  no evidence of  disease,
2 years after the operation.
Discussion
The most common primary malignant neoplasm of
the penis is squamous cell carcinoma, followed by
metastatic  neoplasms  such  as  prostate, bladder,
rectum, kidney and testis, and those  spreading by
direct  extension  from  the  adjacent  structures.
Mesenchymal neoplasms are rare and represent less
than 5% of all types of penile malignant disease.2
According  to  Dehner  and  Smith, who  in  their
classic review3 analyzed 46 primary soft tissue tumors
of  the  penis, leiomyosarcoma  represents  approxi-
mately 13.5 and 6.5% of penile sarcomas and soft
tissue  tumors  in  general, respectively. This  is  in
concordance with the earlier results of Ashley and
Edwards4 where they found an incidence of 5.5%.
To the best of our knowledge, the last well-docu-
mented case was that of Pow-Sang and Orihuela in
19945 and,according to their review,the present case
is the 20th of the deep-seated lesions and the 28th
that has been reported in general.
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Fig. 1. Macroscopic view of the excised tumor, arrowheads indicating the glans penis at the bottom. Note that the urethra is free of
invasion.The tumor size is estimated to be approximately 18 cm.
Fig. 2. On immunohistochemical stains, strong positivity for smooth muscle antigen (SMA, 100) can be seen.Pratt and Ross7 were the ￿ rst authors who classi-
￿ ed penile leiomyosarcomas into two distinct patho-
logical  and  clinical  entities, super￿ cial  and
deep-seated tumors.
Super￿ cial lesions usually present as a tumorlet in
the distal shaft or the penile prepuce,often in middle-
aged  men, and  commonly  it  is  a  slowly  growing
tumor, with low metastatic potential.
Deep lesions, one of which we present here, arise
from the glans penis and from the proximal portions
of the corpora cavernosa or corpus spongiosum, and
occur at a relatively more advanced age.
In  contrast  to  the  super￿ cial  tumors, the  deep
lesions show greater propensity to metastasize and
have therefore poorer prognosis. Clinically they are
poorly circumscribed, ￿ rm non-tender masses that
in￿ ltrate surrounding tissues and can be the cause of
urinary obstruction or urethrocutaneous ￿ stula.8
The  origin  of  the  super￿ cial  type  neoplasm  is
presumed to be the erector pilorum muscle of the
dermis  or  the  smooth  muscular  elements  of  the
subcutaneous  tissue. The  deep-seated  lesions
possibly arise from the smooth muscle cells of the
corpora cavernosa or the corpus spongiosum, or they
may be due to progression of an initially super￿ cial
lesion.5 For the tumors arising in the glans penis the
origin could be from blood vessel walls.6
On  gross  section  they  are  usually  rubbery  in
consistency, well  circumscribed  and  with  white,
yellow, or gray appearance.
Microscopically, they  are  composed  of  spindle-
shaped  smooth  muscle ￿ bers  arranged  into  inter-
lacing fasicles. The importance of mitotic rate and
other nuclear differentiation variables, have not been
analyzed in the literature, but the data show that the
degree of differentiation is reliable in order to predict
the tumor propensity to in￿ ltrate the adjacent struc-
tures or to metastasize. Histologically the two types
are identical.
On  electron microscopy examination myo￿ brils,
dense bodies, and  abundant  pinocytic  vesicles  are
noted, and  a  continuous  basal  lamina  is  present
around most of the tumor cells.9
It  seems  that, of  mesenchymal  penile  tumors,
leiomyosarcomas are more prone to recur and they
become more undifferentiated with each recurrence,1
The  recurrence  rate  is  relatively  similar  in  both
groups,but the metastatic potential is higher in deep-
seated lesion.3
The treatments of choice are (1) surgery, in the
form of local excision, amputation whether partial or
total, or  radical  penectomy, (2)  radiation, or  (3)
chemotherapy. Surgery should aim at the excision of
the tumor mass. Amputation, is the most effective
treatment to prevent recurrences for both types of
penile leiomyosarcoma,5 but the approach should be
individualized, and because super￿ cial tumors tend
to  appear  in  younger  men, these  cases  can  be
managed  by  local  excision  with  negative  surgical
margins whenever this is possible. Deep lesions are
most appropriately  treated  with  a  more aggressive
approach, namely amputation for the distal lesions,
or radical penectomy for the middle or proximal shaft
lesions.
In  contrast  to  squamous  cell  carcinoma  of  the
penis where the excision of the regional lymph nodes
can be considered curative in early stages, this is not
the case in penile leiomyosarcoma,10 and the radia-
tion or excision of regional lymph nodes cannot be
considered to have an in￿ uence on patient survival.5
Pre- or postoperative external beam radiation has
not proved its value in treating penile leiomyosarco-
mas or in increasing survival rates.11 Brachytherapy
has  not  yet  been  reported  as  a  treatment.
Chemotherapy with anthracyclines or etoposide has
provided  poor  results  and, unfortunately, ongoing
trials show that the newer taxanes,have not been suc-
cessful in treating uterine leiomyosarcomas.12
Nevertheless, both  treatment  modalities  can  be
used for palliation in recurrences not amenable to
surgical treatment.
In conclusion, leiomyosarcoma of  the  penis is a
very rare disease cured mainly by surgical interven-
tion. The  effectiveness  of  radiation  therapy  and
chemotherapy  is  debatable, and  the  lack  of  large
series  makes  the  conclusions insecure. Because  of 
the small number of cases so far, the best approach
for  these  malignant  tumors  is  the  collaboration
between the urological surgeon, the pathologist, the
radiotherapist and the medical oncologist in order to
optimize  the  results  for  the  best  interest  of  the
patient.
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